Cardiac angiosarcoma: Utility of [18F]fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of residue, metastases, and treatment response

10Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Cardiac angiosarcomas are a rare form of malignancy. The majority of cases arise from the right atrium as mural masses. These tumors have extremely aggressive behavior, with early clinical symptoms that vary depending on location, size, and extent of the tumor. Most of these patients have a very short survival time. Surgical therapy is considered the best choice of therapy approach in cardiac angiosarcoma patients with nonmetastatic disease, even though the disease is rarely cured. Advanced diagnostic techniques facilitate accurate, noninvasive assessments of cardiac sarcomas. We report a case of a 62-year-old man with cardiac angiosarcoma who had multiple distant metastases that were revealed by [18F]fuorodeoxyglucose positron emission tomography-computed tomography imaging. © 2014 Tokmak et al.

Cite

CITATION STYLE

APA

Tokmak, H., Demir, N., & Demirkol, M. O. (2014). Cardiac angiosarcoma: Utility of [18F]fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of residue, metastases, and treatment response. Vascular Health and Risk Management, 10, 399–401. https://doi.org/10.2147/VHRM.S64286

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free